Compare ALEMBIC with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs PROCTER & GAMBLE HEALTH - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PROCTER & GAMBLE HEALTH ALEMBIC/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 73.4 15.4 475.4% View Chart
P/BV x 6.3 6.2 101.8% View Chart
Dividend Yield % 0.2 7.6 2.1%  

Financials

 ALEMBIC   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ALEMBIC
Mar-18
PROCTER & GAMBLE HEALTH
Dec-18
ALEMBIC/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs723,549 2.0%   
Low Rs341,301 2.6%   
Sales per share (Unadj.) Rs4.7511.4 0.9%  
Earnings per share (Unadj.) Rs6.161.3 10.0%  
Cash flow per share (Unadj.) Rs6.274.0 8.4%  
Dividends per share (Unadj.) Rs0.20440.00 0.0%  
Dividend yield (eoy) %0.418.1 2.1%  
Book value per share (Unadj.) Rs40.7927.8 4.4%  
Shares outstanding (eoy) m267.0316.60 1,608.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.34.7 237.6%   
Avg P/E ratio x8.739.6 21.9%  
P/CF ratio (eoy) x8.532.8 25.9%  
Price / Book Value ratio x1.32.6 49.8%  
Dividend payout %3.3717.9 0.5%   
Avg Mkt Cap Rs m14,13940,257 35.1%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m2071,313 15.8%   
Avg. sales/employee Rs ThNM7,486.7-  
Avg. wages/employee Rs ThNM1,157.6-  
Avg. net profit/employee Rs ThNM897.2-  
INCOME DATA
Net Sales Rs m1,2558,490 14.8%  
Other income Rs m370244 151.8%   
Total revenues Rs m1,6258,734 18.6%   
Gross profit Rs m1111,482 7.5%  
Depreciation Rs m38211 17.9%   
Interest Rs m20-   
Profit before tax Rs m4421,514 29.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m24563 4.3%   
Profit after tax Rs m1,6301,017 160.2%  
Gross profit margin %8.917.5 50.7%  
Effective tax rate %5.437.1 14.6%   
Net profit margin %129.812.0 1,083.5%  
BALANCE SHEET DATA
Current assets Rs m1,86715,343 12.2%   
Current liabilities Rs m5911,960 30.2%   
Net working cap to sales %101.6157.6 64.5%  
Current ratio x3.27.8 40.3%  
Inventory Days Days9449 193.4%  
Debtors Days Days7428 258.5%  
Net fixed assets Rs m1,7911,209 148.1%   
Share capital Rs m534166 321.7%   
"Free" reserves Rs m10,32415,235 67.8%   
Net worth Rs m10,85815,401 70.5%   
Long term debt Rs m410-   
Total assets Rs m11,59117,595 65.9%  
Interest coverage x260.9NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.10.5 22.4%   
Return on assets %14.15.8 243.4%  
Return on equity %15.06.6 227.2%  
Return on capital %15.210.3 148.1%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m191,636 1.2%   
Fx outflow Rs m2644,368 6.0%   
Net fx Rs m-244-2,732 8.9%   
CASH FLOW
From Operations Rs m236-1,304 -18.1%  
From Investments Rs m-22412,697 -1.8%  
From Financial Activity Rs m-27-301 8.9%  
Net Cashflow Rs m-1511,093 -0.1%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.2 18.2 1.1%  
FIIs % 9.7 1.0 970.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 29.1 89.7%  
Shareholders   54,701 28,591 191.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   UNICHEM LAB  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  NEULAND LABS  

Compare ALEMBIC With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 14, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS